(2020). A ltered repertoire diversity and dis- ease-associated clonal expansions revealed by T cell receptor immuno- sequencing in ankylosing spondylitis patients. Arthritis Rheumatol. 72, 1289–1302. https://doi.org/10.1002/art.41252 .https://www.ncbi.nlm.nih. gov/pubmed/32162785 . Hellmann, M.D., Nathanson, T., Rizvi, H., Creelan, B.C., Sanchez-Vega, F., Ahuja, A., Ni, A., Novik, J.B., Mangarin, L.M., Abu-Akeel, M., et al. (2018).Genomic features of response to combination immunotherapy in patientswith advanced non-small-cell lung cancer. Cancer Cell 33, 843–852.e4. https://doi.org/10.1016/j.ccell.2018.03.018 . Hellmann, M.D., Paz-Ares, L., Bernabe Caro, R., Zurawski, B., Kim, S.W., Carcereny Costa, E., Park, K., Alexandru, A., Lupinacci, L., de la MoraJimenez, E., et al. (2019). Nivolumab plus ipilimumab in advanced non-small-cell lung cancer. N. Engl. J. Med. 381, 2020–2031. https://doi.org/10. 1056/NEJMoa1910231 .https://www.ncbi.nlm.nih.gov/pubmed/31562796 . Helmink, B.A., Reddy, S.M., Gao, J., Zhang, S., Basar, R., Thakur, R., Yizhak, K., Sade-Feldman, M., Blando, J., Han, G., et al.